These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 21235580)

  • 1. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
    Barakat NS; Almurshedi AS
    J Pharm Pharmacol; 2011 Feb; 63(2):169-78. PubMed ID: 21235580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: in vitro/in vivo evaluation.
    Barakat NS; Almurshedi AS
    J Microencapsul; 2011; 28(2):122-33. PubMed ID: 21110773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying the Taguchi design for optimized formulation of sustained release gliclazide chitosan beads: an in vitro/in vivo study.
    Varshosaz J; Tavakoli N; Minayian M; Rahdari N
    AAPS PharmSciTech; 2009; 10(1):158-65. PubMed ID: 19205888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
    Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide.
    Sharma VK; Mazumder B
    Int J Biol Macromol; 2014 May; 66():15-25. PubMed ID: 24530641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel gastroretentive drug delivery system of gliclazide: hollow beads.
    Awasthi R; Kulkarni GT
    Drug Dev Ind Pharm; 2014 Mar; 40(3):398-408. PubMed ID: 23418961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
    Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
    Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of two hydrophobic polymers on the release of gliclazide from their matrix tablets.
    Hussain T; Saeed T; Mumtaz AM; Javaid Z; Abbas K; Awais A; Idrees HA
    Acta Pol Pharm; 2013; 70(4):749-57. PubMed ID: 23923399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules.
    Pal D; Nayak AK
    AAPS PharmSciTech; 2011 Dec; 12(4):1431-41. PubMed ID: 22038475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations.
    Das S; Ng KY; Ho PC
    J Drug Target; 2011 Jul; 19(6):446-57. PubMed ID: 20684731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel gastroretentive floating particulate drug delivery system of gliclazide.
    Awasthi R; Kulkarni GT
    Curr Drug Deliv; 2012 Sep; 9(5):437-51. PubMed ID: 22920574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
    Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
    Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
    Nayak UY; Gopal S; Mutalik S; Ranjith AK; Reddy MS; Gupta P; Udupa N
    J Microencapsul; 2009 May; 26(3):214-22. PubMed ID: 18819029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of 5-Fluorouracil loaded chitosan microspheres by a two-step solidification method.
    Sun Y; Gu L; Gao Y; Gao F
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):891-5. PubMed ID: 20606332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
    Agnihotri SA; Aminabhavi TM
    J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swelling behavior of cross-linked dextran hydrogels and preliminary Gliclazide release behavior.
    Bajpai SK; Chand N; Tiwari S; Soni S
    Int J Biol Macromol; 2016 Dec; 93(Pt A):978-987. PubMed ID: 27664925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing chitosan-tripolyphosphate microparticles with desired size for specific pharmaceutical or forensic applications.
    Hejjaji EM; Smith AM; Morris GA
    Int J Biol Macromol; 2017 Feb; 95():564-573. PubMed ID: 27894825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triamcinolone-loaded glutaraldehyde cross-linked chitosan microspheres: prolonged release approach for the treatment of rheumatoid arthritis.
    Dhanaraju MD; Elizabeth S; Gunasekaran T
    Drug Deliv; 2011 Apr; 18(3):198-207. PubMed ID: 21028952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.